Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Parish

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Nature|July 3, 2025
Rewiring endogenous genes in CAR T cells for tumour-restricted payload deliveryAmanda X Y Chen, Kah Min Yap, Joelle S Kim, et al.
Nature|April 10, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacyJack D Chan, Christina M Scheffler, Isabelle Munoz, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Immunity|May 22, 2024
The CD8<sup>+</sup> T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsWillem Van Der Byl, Simone Nüssing, Timothy J Peters, et al.
Nature Communications|November 2, 2023
A<sub>2A</sub>R eGFP reporter mouse enables elucidation of A<sub>2A</sub>R expression dynamics during anti-tumor immune responsesKirsten L Todd, Junyun Lai, Kevin Sek, et al.
Nature Immunology|February 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8<sup>+</sup> T cells in lymph nodesJunyun Lai, Cheok Weng Chan, Jesse D Armitage, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Nature|July 3, 2025
Rewiring endogenous genes in CAR T cells for tumour-restricted payload deliveryAmanda X Y Chen, Kah Min Yap, Joelle S Kim, et al.
Nature|April 10, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacyJack D Chan, Christina M Scheffler, Isabelle Munoz, et al.
Pageof 6